Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality & Regulatory Systems
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
BioLife Solutions

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Cryopreservations/Development of a...

Development of a Mouse Myeloid Progenitor Cell Therapeutic for Treatment of HS-ARS in BALB/c mice

Pub_2-Maxey_CLT-008_2014Development of a Mouse Myeloid Progenitor Cell Therapeutic for Treatment of HS-ARS in BALB/c mice

Post navigation

Identification of CD73, CD90 and CD105 by qPCR in Cryopreserved Human Cord Tissue
Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy
Search for:

Blog Archives

Signup Area

Sign Up for Email Updates

Biolife Logo

  • Products
  • Company
  • Evidence
  • Investors
  • Blog
  • Ask the Scientists
  • Press Releases
  • Contact
© 2018 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
  • twitter
  • linkedin
  • facebook